Thailand and other Asian countries have experienced an increase in the prevalence of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). 1 This is probably due to both the increasing disease awareness and accessibility to diagnostic serological testing and magnetic resonance imaging (MRI). Although MS, NMOSD, and MOGAD have distinct mechanisms, prognoses, and treatments, they share common clinical features or even mimic other conditions. It is not uncommon for the diagnostician to be unconfident to make a definite diagnosis at the first presentation, especially with the lack of the typical presentations, MRI findings, and positive serological markers. Moreover, other mimic diseases in Asia, which are somewhat different from Western countries, also need excluding. Herein, we summarize the typical presentations of MS, NMOSD, and MOGAD along with the evolution and obstacles in diagnosing these diseases in Thailand. We also highlight the essential practical points to discriminate between them.
| UTILIZING THE D IAG NOS TI C CRITERIA OF MS , NMOS D, AND MOG ADThe diagnostic criteria for both MS and NMOSD have been revised many times as our understanding of the diseases has improved.Revised criteria have enabled earlier diagnosis, provided prompt treatment, and potentially prevented future disability. However, MS and NMOSD are only diagnosed if the current criteria are met, and alternative diagnoses are excluded.
A significant milestone in improving diagnosis was the 2001McDonald criteria incorporating MRI findings to serve as surrogates